Alcon employs former Novartis CFO
This article was originally published in Clinica
Executive Summary
Eye care company Alcon has appointed Robert Karsunky to the role of CFO. Mr Karsunky previously held the same position at Novartis’s consumer health division. Novartis has a 77% stake in Alcon, and is currently battling it out with shareholders of the Huenenberg, Switzerland-based firm to buy the remaining 23%. Mr Karsunky will take up his new position on 1 November, when he will replace Richard Croarkin. Mr Croarkin will remain a member of the firm’s executive leadership team until 30 November to help with the transition, after which he will return to a financial position at Nestlé, where he was employed from 1994 until 2007.